week one semaglutide and 4 lbs down! 💪🏻 #weightlossprogress #semaglutide #weightlossjouney @WeightCare Weight Loss Program | Novuskin

While the peptide appeared well tolerated in these trials, the absence of reproducible clinical benefit meant the molecule did not progress to approval or further late-stage studies

Nucleic Acids Res 45 , 1096910977 (2017)

I would just throw on some sweatpants or joggers and just go

It is listed on the PBS for patients who fulfil the following criteria: an eGFR of 25 mL/min/1.73 m 2 or greater an ACR of 22.6 mg/mmol or greater must be on a stable dose of either an ACE inhibitor or ARB must not have established HFrEF must be on an SGLT-2 inhibitor unless medically contraindicated or intolerant (refer to the full PBS clinical criteria at: Combination therapy Some evidence suggests that combination therapy with SGLT-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and CKD reduces the risk of CV events and the mineralocorticoid receptor antagonist-associated risk of hyperkalaemia without a significant interaction between the two drugs